Cargando…

Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control

BACKGROUND: The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) stands to significantly reduce tobacco-related mortality by accelerating the introduction of evidence-based tobacco control measures. However, the extent to which States Parties have implemented the Conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Fooks, Gary Jonas, Smith, Julia, Lee, Kelley, Holden, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343400/
https://www.ncbi.nlm.nih.gov/pubmed/28274267
http://dx.doi.org/10.1186/s12992-017-0234-8
_version_ 1782513356367724544
author Fooks, Gary Jonas
Smith, Julia
Lee, Kelley
Holden, Chris
author_facet Fooks, Gary Jonas
Smith, Julia
Lee, Kelley
Holden, Chris
author_sort Fooks, Gary Jonas
collection PubMed
description BACKGROUND: The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) stands to significantly reduce tobacco-related mortality by accelerating the introduction of evidence-based tobacco control measures. However, the extent to which States Parties have implemented the Convention varies considerably. Article 5.3 of the FCTC, is intended to insulate policy-making from the tobacco industry’s political influence, and aims to address barriers to strong implementation of the Convention associated with tobacco industry political activity. This paper quantitatively assesses implementation of Article 5.3’s Guidelines for Implementation, evaluates the strength of Parties’ efforts to implement specific recommendations, and explores how different approaches to implementation expose the policy process to continuing industry influence. METHODS: We cross-referenced a broad range of documentary data (including FCTC Party reports and World Bank data on the governance of conflicts of interest in public administration) against Article 5.3 implementation guidelines (n = 24) for 155 Parties, and performed an in-depth thematic analysis to examine the strength of implementation for specific recommendations. RESULTS: Across all Parties, 16% of guideline recommendations reviewed have been implemented. Eighty-three percent of Parties that have taken some action under Article 5.3 have introduced less than a third of the guidelines. Most compliance with the guidelines is achieved through pre-existing policy instruments introduced independently of the FCTC, which rarely cover all relevant policy actors and fall short of the guideline recommendations. Measures introduced in response to the FCTC are typically restricted to health ministries and not explicit about third parties acting on behalf of the industry. Parties systematically overlook recommendations that facilitate industry monitoring. CONCLUSION: Highly selective and incomplete implementation of specific guideline recommendations facilitates extensive ongoing opportunities for industry policy influence. Stronger commitment to implementation is required to ensure consistently strong compliance with the FCTC internationally. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12992-017-0234-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5343400
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53434002017-03-10 Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control Fooks, Gary Jonas Smith, Julia Lee, Kelley Holden, Chris Global Health Research BACKGROUND: The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) stands to significantly reduce tobacco-related mortality by accelerating the introduction of evidence-based tobacco control measures. However, the extent to which States Parties have implemented the Convention varies considerably. Article 5.3 of the FCTC, is intended to insulate policy-making from the tobacco industry’s political influence, and aims to address barriers to strong implementation of the Convention associated with tobacco industry political activity. This paper quantitatively assesses implementation of Article 5.3’s Guidelines for Implementation, evaluates the strength of Parties’ efforts to implement specific recommendations, and explores how different approaches to implementation expose the policy process to continuing industry influence. METHODS: We cross-referenced a broad range of documentary data (including FCTC Party reports and World Bank data on the governance of conflicts of interest in public administration) against Article 5.3 implementation guidelines (n = 24) for 155 Parties, and performed an in-depth thematic analysis to examine the strength of implementation for specific recommendations. RESULTS: Across all Parties, 16% of guideline recommendations reviewed have been implemented. Eighty-three percent of Parties that have taken some action under Article 5.3 have introduced less than a third of the guidelines. Most compliance with the guidelines is achieved through pre-existing policy instruments introduced independently of the FCTC, which rarely cover all relevant policy actors and fall short of the guideline recommendations. Measures introduced in response to the FCTC are typically restricted to health ministries and not explicit about third parties acting on behalf of the industry. Parties systematically overlook recommendations that facilitate industry monitoring. CONCLUSION: Highly selective and incomplete implementation of specific guideline recommendations facilitates extensive ongoing opportunities for industry policy influence. Stronger commitment to implementation is required to ensure consistently strong compliance with the FCTC internationally. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12992-017-0234-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-08 /pmc/articles/PMC5343400/ /pubmed/28274267 http://dx.doi.org/10.1186/s12992-017-0234-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Fooks, Gary Jonas
Smith, Julia
Lee, Kelley
Holden, Chris
Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control
title Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control
title_full Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control
title_fullStr Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control
title_full_unstemmed Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control
title_short Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control
title_sort controlling corporate influence in health policy making? an assessment of the implementation of article 5.3 of the world health organization framework convention on tobacco control
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343400/
https://www.ncbi.nlm.nih.gov/pubmed/28274267
http://dx.doi.org/10.1186/s12992-017-0234-8
work_keys_str_mv AT fooksgaryjonas controllingcorporateinfluenceinhealthpolicymakinganassessmentoftheimplementationofarticle53oftheworldhealthorganizationframeworkconventionontobaccocontrol
AT smithjulia controllingcorporateinfluenceinhealthpolicymakinganassessmentoftheimplementationofarticle53oftheworldhealthorganizationframeworkconventionontobaccocontrol
AT leekelley controllingcorporateinfluenceinhealthpolicymakinganassessmentoftheimplementationofarticle53oftheworldhealthorganizationframeworkconventionontobaccocontrol
AT holdenchris controllingcorporateinfluenceinhealthpolicymakinganassessmentoftheimplementationofarticle53oftheworldhealthorganizationframeworkconventionontobaccocontrol